1. Home/
  2. Compounds/
  3. selumetinib:decitabine (4:1 mol/mol)

selumetinib:decitabine (4:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:decitabine (4:1 mol/mol)
PharmacoGx selumetinib:decitabine (4:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:decitabine (4:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA SPRY4 CTRPv2 pan-cancer AAC 0.16 9e-06
mRNA TAPT1 CTRPv2 pan-cancer AAC 0.16 9e-06
mRNA SH3TC2 CTRPv2 pan-cancer AAC 0.17 1e-05
mRNA VASN CTRPv2 pan-cancer AAC -0.16 1e-05
mRNA PLCB2 CTRPv2 pan-cancer AAC 0.16 1e-05
mRNA ERBB3 CTRPv2 pan-cancer AAC 0.18 1e-05
mRNA AAED1 CTRPv2 pan-cancer AAC -0.16 1e-05
mRNA SNX25 CTRPv2 pan-cancer AAC -0.16 1e-05
mRNA SNTA1 CTRPv2 pan-cancer AAC -0.15 1e-05
mRNA RABAC1 CTRPv2 pan-cancer AAC -0.15 1e-05
Download CSV